Heikki Lanckriet

Company: 4basebio

Job title: CEO/CSO

Seminars:

Synthetic, enzymatically produced DNA for use in DNA vaccines 2:15 pm

Exploring how 4bbDNA™ confers several benefits over plasmid DNA for use in DNA vaccines, including: Lack of bacterial backbone confers safety benefits and enables dose reduction as compared to plasmid DNA, possibility of tuning immunostimulatory properties of DNA constructs, and greatly reduced timelines of GMP-grade material Collaborating with Takis Biotech and Neomatrix on neoantigen DNA…Read more

day: Day One